Shalby Q2 FY27 Results: Consolidated Net Profit ₹7.89 Crore on Total Income of ₹318 Crore
- Earnings
- Healthcare services
Reviewed byRachit TripathiBlacklitt Research
Shalby (NSE: SHALBY) reported consolidated total income of ₹318.22 crore and consolidated net profit of ₹7.89 crore for the quarter ended 30 Sep 2026, and standalone total income of ₹250.61 crore and standalone net profit of ₹23.50 crore, according to its results released on 3 Nov 2026.
Key highlights
Consolidated
Including its subsidiaries
- Total income: ₹318.22 crore, up 9.8% YoY and down 6.0% QoQ
- Net profit and EPS: ₹7.89 crore, up 8.4% YoY and down 24.9% QoQ; basic EPS ₹0.73
- Finance costs: ₹11.05 crore, up 14.6% YoY
Standalone
The company on its own, without its subsidiaries
- Total income: ₹250.61 crore, up 9.1% YoY and down 3.3% QoQ
- Net profit and EPS: ₹23.50 crore, up 19.0% YoY and down 6.2% QoQ; basic EPS ₹2.19
- Tax expense: ₹8.05 crore, down 25.5% YoY
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 318.22 | 289.91 | +9.8% | 338.64 | -6.0% | |
| Revenue from operations | 313.17 | 285.43 | +9.7% | 331.22 | -5.4% |
| Other income | 5.04 | 4.48 | +12.7% | 7.41 | -32.0% |
| 7.89 | 7.28 | +8.4% | 10.50 | -24.9% | |
| Profit before tax | 16.47 | 19.07 | -13.6% | 19.70 | -16.4% |
| Finance costs | 11.05 | 9.65 | +14.6% | 10.57 | +4.6% |
| Depreciation | 18.92 | 17.37 | +8.9% | 18.74 | +0.9% |
| Tax expense | 8.58 | 11.80 | -27.3% | 9.19 | -6.7% |
| Net profit margin | 2.48% | 2.51% | -0.03 pp | 3.10% | -0.62 pp |
| EPS, basic (₹) | 0.73 | 0.68 | +7.4% | 0.98 | -25.5% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Consolidated net profit grew more slowly than income. Net profit rose 8.4% to ₹7.89 crore while total income rose 9.8%, and profit before tax fell 13.6% to ₹16.47 crore.
Other income is a small part of the result. At ₹5.04 crore it is 1.6% of total income and 30.6% of profit before tax. Finance costs of ₹11.05 crore are 3.5% of total income, up 14.6% on the year-earlier quarter.
The attributable figure differs from net profit.
The segment note shows the implant business at a loss. Manufacturing and Trading of Implants recorded revenue of ₹29.96 crore and a segment loss of ₹11.64 crore, while Healthcare Services recorded revenue of ₹283.21 crore.
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 250.61 | 229.78 | +9.1% | 259.07 | -3.3% | |
| Revenue from operations | 245.32 | 223.63 | +9.7% | 253.79 | -3.3% |
| Other income | 5.29 | 6.15 | -14.0% | 5.28 | +0.2% |
| 23.50 | 19.76 | +19.0% | 25.07 | -6.2% | |
| Profit before tax | 31.55 | 30.56 | +3.2% | 33.89 | -6.9% |
| Finance costs | 3.19 | 4.28 | -25.6% | 3.08 | +3.6% |
| Depreciation | 10.95 | 9.94 | +10.2% | 10.80 | +1.4% |
| Tax expense | 8.05 | 10.80 | -25.5% | 8.82 | -8.7% |
| Net profit margin | 9.38% | 8.60% | +0.78 pp | 9.68% | -0.30 pp |
| EPS, basic (₹) | 2.19 | 1.84 | +19.0% | 2.33 | -6.0% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone net profit rose 19.0% to ₹23.50 crore, faster than total income, which rose 9.1%. Profit before tax rose only 3.2% to ₹31.55 crore, and tax expense fell 25.5% to ₹8.05 crore, so the tax charge takes a smaller share of profit than a year earlier.
Finance costs fell 25.6% to ₹3.19 crore, and other income fell 14.0% to ₹5.29 crore, which is 16.8% of profit before tax.
Consolidated net profit of ₹7.89 crore is ₹15.61 crore lower than standalone net profit of ₹23.50 crore, while consolidated total income is ₹67.61 crore higher than standalone.
Inference
The board approved Mr. Shanay Vikram Shah's appointment as Whole-Time Director for five years and Mr. Tushar Shah's appointment as Executive Director with effect from 3 Nov 2026, both subject to shareholder approval by postal ballot. E-voting ends on 4 Dec 2026 and the result is to be declared on 5 Dec 2026.
The filing says Shalby Medtech Limited acquired the balance 10,000 equity shares of Shalby Global Technologies Pte. Ltd., making it a wholly owned subsidiary from 12 Aug 2026. The filing does not state the price paid or the effect of this on results.
The filing does not give a reason for the fall in consolidated profit before tax, the remuneration of the new directors, or any dividend decision.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
